Navigation Links
Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting
Date:7/20/2009

MADISON, N.J., July 20 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) today announced that its stockholders overwhelmingly approved the adoption of its merger agreement with Pfizer (NYSE: PFE) at Wyeth's Annual Meeting of Stockholders. Based on a preliminary vote count by Wyeth's transfer agent, over 98 percent of shares voted favored the merger. Approval of the merger agreement required an affirmative vote of the majority of outstanding shares.

Commenting on the transaction, Bernard Poussot, Wyeth's Chairman, President and Chief Executive Officer, stated: "The merger is in the best interests of our Company and our stockholders. Combined with Pfizer, we see opportunities for increased scale where needed and resources to become the world's premier biopharmaceutical company and an industry leader in human, consumer and animal healthcare, in both disease prevention and treatment. The combined organization will continue Wyeth's mission to bring innovative medical solutions to patients around the world."

Mr. Poussot also said that the Pfizer transaction resulted from recognition of Wyeth's success in research and development and its early entry into biotechnology, which led to $8 billion in revenue from biopharmaceutical and vaccine products in 2008, making Wyeth the fourth largest biotechnology company in the world.

Mr. Poussot also provided an update on the merger integration planning process with Pfizer. "Wyeth is very engaged in the integration planning process and is working with Pfizer to continue the strategies that have led to our successes. Pfizer views this merger unlike others it has done in the past. They are adding entire businesses and capabilities to enable a significant pre
'/>"/>

SOURCE Wyeth
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
2. Wyeth Announces Holder Right to Surrender Convertible Debentures
3. Wyeth Declares Common Stock Dividend
4. New Phase 3 Data Continue to Indicate that Wyeths Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
5. Wyeth Sets Webcast and Conference Call For 2009 Second Quarter Earnings
6. Wyeth Announces Full Redemption of $2 Convertible Preferred Stock
7. Wyeth Declares Common and Preferred Stock Dividends
8. Wyeth Sets Webcast and Conference Call for 2009 First Quarter Earnings
9. Wyeth to Present at the SG Cowen & Co. 29th Annual Healthcare Conference
10. Wyeth to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
11. Wyeth Names Michael Kamarck President, Technical Operations & Product Supply

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...ov. 19 Danish Prince Joachim inaug...nol plant in Kalundborg, Denmark, on Wednesday, No...t and largest 2nd generation ethanol demonstration... used in the plant,s innovative process for conver...o, was the first to market with commercial enzymes...
(Date:11/19/2009)...Y., Nov. 19 Dr. Mate Hidvegi, inve...nds to a press release issued on November 17 by Bi...or making false and self-serving statements about ...r. Hidvegi stated from his office in Budapest, Hun...n Avemar does not apply to AveULTRA, www.aveultr...
(Date:11/19/2009)...v. 19 NeoStem, Inc. (NYS...he following letter to its shareholders, discussin...of China Biopharmaceuticals Holdings, Inc. (CHBP),... the People,s Republic of China. The merger gives ...Pharmaceutical Co. Ltd., CHBP,s primary operating ...
(Date:11/19/2009)... Pa. and WALTHAM, Mass., Nov. 19 A...urces find that the leading driver of antibiotic s...d-spectrum activity against gram-positive and gram...ms that can cause nosocomial pneumonia, surveyed E... for agents that provide appropriate coverage agai...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
...e Corporation, a,Georgia-based biotech company, to...sory Board (SAB) to collaborate on the development...and guide future therapeutic,and diagnostic projec...tific founder Richard Meagher, PhD, Chief,Scientif...essor at the,University of Georgia, and inventor o...
...simo (Nasdaq:,MASI), the inventor of Pulse CO-Oxim...pulse oximetry, today announced,that all customers...agship,product, will now receive Desat Index 3D Al...imeters typically alarm based on large and,isolate...esaturation".,However, published research has show...
...ABB accreditation bolsters PCT,s commitment to qua... distribution. , Hackensa... Therapy, LLC (PCT) announced today that it has ob... Blood Activities - Processing, Storage, Distribut...oactive to 1 April 2008 after satisfactorily passi...
Other Biology Technology:Abeome Forms First Class Scientific Advisory Board 2Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices 2Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices 3Progenitor Cell Therapy Secures Industry Accreditation 2Progenitor Cell Therapy Secures Industry Accreditation 3Progenitor Cell Therapy Secures Industry Accreditation 4
(Date:11/20/2009)...s Energy Research Center (ERC) has been awarded a ...develop methods of recovering and reusing the heat... 2 ) compression process in a carbon capture syste...te carbon capture and sequestration, or storage (C...use gas, emitted into the atmosphere by coal-fired...
(Date:11/19/2009)...er ants, which cultivate fungus for food, have man...dd to the list: the ant farmers, like their human ...o make their gardens grow. The finding, reported t...ents a previously unknown symbiosis between ants a...ter ants have come to dominate the American tropic...
(Date:11/19/2009)...bor, NY A four-year, multi-institutional effort c...) scientists culminated today in publication of a ... revealing in unprecedented detail the DNA sequenc...commonly called by North American consumers, is on...t valuable agricultural crop grown in the United S...
Breaking Biology News(10 mins):Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Like humans, ants use bacteria to make their gardens grow 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4BioMarin Acquires Huxley Pharmaceuticals Inc 5703 1BioMarin Acquires Huxley Pharmaceuticals Inc 5703 2BioMarin Acquires Huxley Pharmaceuticals Inc 5703 3BioMarin Acquires Huxley Pharmaceuticals Inc 5703 4BioMarin Acquires Huxley Pharmaceuticals Inc 5703 5BioMarin Acquires Huxley Pharmaceuticals Inc 5703 6Heart Disease Gender Gap Narrows 60108 1Heart Disease Gender Gap Narrows 60108 2Heart Disease Gender Gap Narrows 60108 3Slipper shaped blood cells 10529 1
... is a hereditary blood disease, primarily affectin...entially life-threatening ,bleeds,. About one in 6...evere, moderate or mild form. People with haemophi...ctor VIII clotting protein. , Professor Denisa Wag...eaking discoveries that provide hope of an alterna...
... have discovered that tumors release fatty acids t...ll them. Consequently, strategies that reduce the ...ive a boost to anti-cancer therapeutics. The detai... of the Journal of Lipid Research, an American Soc...l. , Several forms of anti-cancer therapy rely on ...
...enomic researchers headed by biologists at New Yor...enomics, in collaboration with researchers at Harv...x Biosciences, has mapped out a preliminary molecu...n, offering for the first time a global look at ho...lar organism. The findings are reported in the Aug...
Other Biology News:Promising therapies for haemophilia & heart disease 2Researchers discover new tumor defense system 2NYU biologists map out early stages of embryo formation 2
Sheep Anti-11-DEOXY-CORTICOSTERONE (-OCMO) Polyclonal Antibody, Unconjugated from AbD Serotec
Equine Immunoglobulin G from Equitech-Bio
Mouse Anti-Human IFN-Gamma RC2 (CD118) Non-Neutralizing Monoclonal Antibody, Unconjugated, Clone MMHGR-2 from PBL InterferonSource
Rat CINC-2 beta, Unconjugated from R&D Systems
Biology Products: